1. Cheng, Elaine, Trombetta, Sergio E, Kovacs, Daniela, Picardo, Mauro, Halaban, Ruth. 2006. Rab33A: characterization, expression, and suppression by epigenetic modification. In The Journal of investigative dermatology, 126, 2257-71. doi:. https://pubmed.ncbi.nlm.nih.gov/16810302/
2. Jacobsen, Marc, Repsilber, Dirk, Gutschmidt, Andrea, Ziegler, Andreas, Kaufmann, Stefan H E. 2005. Ras-associated small GTPase 33A, a novel T cell factor, is down-regulated in patients with tuberculosis. In The Journal of infectious diseases, 192, 1211-8. doi:. https://pubmed.ncbi.nlm.nih.gov/16136464/
3. D'Antonio, Luigi, Fieni, Cristiano, Ciummo, Stefania Livia, Sorrentino, Carlo, Di Carlo, Emma. . Inactivation of interleukin-30 in colon cancer stem cells via CRISPR/Cas9 genome editing inhibits their oncogenicity and improves host survival. In Journal for immunotherapy of cancer, 11, . doi:10.1136/jitc-2022-006056. https://pubmed.ncbi.nlm.nih.gov/36927528/
4. Jais, J-P, Haioun, C, Molina, T J, Salles, G, Leroy, K. 2008. The expression of 16 genes related to the cell of origin and immune response predicts survival in elderly patients with diffuse large B-cell lymphoma treated with CHOP and rituximab. In Leukemia, 22, 1917-24. doi:10.1038/leu.2008.188. https://pubmed.ncbi.nlm.nih.gov/18615101/
智鼠故事 
